We turn movement into clinical-grade data.
AAI Health surfaces musculoskeletal risk before it becomes a claim — and proves whether treatment actually works. A clinical-grade assessment from any phone or computer. No wearables.
MSK is the #1 cost in self-funded healthcare. Everyone manages it blind. We don't. We turn movement into clinical-grade data.
burden · 5.8% of GDP
per year
an MSK condition
30-min assessment
Every diagnosis got a real test.
Function is still a guess.
A few hundred years ago, all of medicine ran on guesswork. Three of these were retired. One never was.
Then — a finger on the pulse, a guessed number.
Now — the cuff. Exact, every time.
Then — guessed from the look of the eyes.
Now — a blood panel. Precise.
Then — tasted in the urine and blood.
Now — a glucose meter. Instant.
The most expensive sector in American medicine is still measured the way it was before electricity — back when diabetes was found by taste.
A system failing the employer and the patient at the same time.
Claims surface months late
By the time an injury becomes a claim, you’re already paying for it. There is no early warning.
No objective baseline
Pain and function are recorded subjectively. That inflates cost and hides who is actually at risk.
Unconscionable variability
Diagnosis, recovery, and protocols differ wildly. There is no standard and no way to compare.
The most misdiagnosed, mistreated, and costly conditions in employer health.
Annual U.S. burden — 5.8% of GDP, direct + indirect
Workdays lost per year — more than any other condition
U.S. adults live with a musculoskeletal condition
Higher rate of anxiety & depression with chronic pain
Sources: U.S. Bone & Joint Initiative, BMUS 4th ed. · National Health Interview Survey 2019, published in PAIN (2024).
Most MSK apps are vitamins. We're the blood test.
Exercise apps hand everyone the same routine without ever screening whether they need it. AAI Health screens first — what’s wrong, who’s at risk, and whether treatment is actually working.
Risk, surfaced early
Objective MSK risk surfaced before it becomes a claim.
Injury, foreseen
Identify who is heading toward injury — before it happens.
Treatment, proven
Prove whether PT, meds, or surgery work — in weeks, not months.
Meet Jessica — a clinical-grade assessment from any phone or computer.
An objective measurement of a participatory test — repeatable, standardized, and completely wearable-free.
- Pain Mapping — a natural conversation captures the history of discomfort.
- Clinical Intake — voice-enabled dialogue records structured clinical answers.
- Movement Capture — camera-based range-of-motion measured to a tenth of a degree.
45+ movements. 1,000+ data points. 30 minutes. Zero wearables.
Patient opens the app
Any camera-enabled phone or tablet.
Jessica guides the session
Movements, postures & ROM tests.
Computer vision captures
1,000+ unique data points recorded.
Normal clears, risk routes
Flagged results route to expert care.
Standardized movements
Data points captured
Remote & wearable-free
Average session
One closed loop: the patient, the AI, and the physician.
The AI measures. The physician diagnoses and directs care. The next assessment proves whether it worked.
This is the regulatory posture, not just the product. The platform measures and structures; credentialed physicians diagnose and treat. The loop is the ecosystem — and the outcomes-linked dataset it generates is the moat.
Clinically structured reports that redirect spend.
Every movement measured against unit-aware target windows, with status flags that surface risk at a glance — the raw material behind the population analytics employers and payers buy.
Head-to-toe MSK
Complete clinical summary of the whole musculoskeletal picture.
Range of motion
Isolated measurements & deviations from target windows.
Disability scoring
Standardized scoring, comparable across a population.
Any stakeholder
User-defined sections for employers, payers, or work-comp.
Consistent, reproducible output — the same assessment, scored the same way, every time. That consistency is what makes it comparable across a population and over time.
Five years and 100,000+ data points of real-world clinical signal — generated inside a working practice.
Deployed with real patients inside a working pain practice
Data points collected and analyzed
Engagement among symptomatic patients
Patients · paired baseline & follow-up outcomes
Every measured outcome moved in the right direction.
70 patients, paired baseline and follow-up structured assessments under guided corrective care.
A different axis than the exercise apps.
Distribution, capital, and brand at $2–6B scale.
Physician-interpreted objective measurement, risk prediction, and treatment validation — in one closed clinical loop.
Three forces converging at once.
Agentic AI just made it possible
We built the computer vision in 2020. Only at the end of 2025 could AI guide a clinical-grade assessment at scale.
Employers are demanding this now
Self-funded plans name MSK their #1 cost and are actively moving to direct provider contracting.
The GLP-1 wave needs us
Weight comes off — the MSK damage and deconditioning stay. We’re the missing other half of that care.
A broken system, made whole: Jack's story.
Former athlete. Now a construction worker, father, and husband to Diane.
Risk was never measured
Jack hurts his back at work. He never had an MSK screen — his risk was invisible until it became a claim.
Months of unverifiable PT
Subjective improvement no one could measure. Then surgery — and more pain.
Caught early. Proven care.
Injury caught early. Objective data guides care. Outcomes tracked, risk reduced — Jack returns to work.
What it’s worth: one avoided surgery pays for hundreds of screens.
Three buyers. One objective standard.
The self-funded employer
Self-funded operators (500–2,500 employees) in manufacturing, logistics & distribution — moving to direct contracting. A single avoided surgery pays for hundreds of screens.
The gatekeeper with a book
Regional benefits consultants and point-solution platforms who need an MSK differentiator to defend fees. One relationship becomes many contracts.
The objectivity buyer
WC carriers and TPAs managing MSK claim duration — objective function data and consistency flags for variances that can’t be medically explained.
The physician who saw the opioid crisis coming — now building the standard that comes next.
AAI Health isn’t a tech company that hired a medical advisor. It’s founded and led by one of the most credentialed interventional pain physicians in the country — the first U.S. pain physician to work with the World Health Organization’s Department of Substance Abuse, who warned of the OxyContin epidemic more than a decade before the CDC, and who has never prescribed OxyContin or oxycodone in three decades of practice.
The clinical logic inside this platform is his — now formalized into protocols any credentialed reviewer can apply, designing the founder out of the critical path on purpose.
Physician-led. Built to outlast any one of us.
AAI Health owns the clinical logic and the outcomes-linked dataset — the moat — while its arms deliver the care and the engine.
National Pain Centers
The physician-led practice where the ecosystem was built and validated on real patients.
Deep Mind Healthcare
The computer-vision & motion-capture engine behind Jessica. AAI owns the clinical logic and the outcomes-linked dataset.
Physician-led, technology-built.
A double board-certified founder, a GLP-1 clinical bridge, an operating COO, and a deep AI/computer-vision engineering team — backed by a clinical network of credentialed MSK experts reviewing assessments today.
Jay Joshi, MD®
Double board-certified pain physician
Grant Reffell, DC
Six years operating the company
Shoriful
Two-time exit founder
Mehedi
AI & computer vision
Asif
iOS · Swift · Flutter
Nirjor
CV & LLM applications
Meraj
On-device AI
Desha
Next.js · React · TS
Sadi
Univ. of Tsukuba
Mitul Desai, MD
Double board-certified · the GLP-1 clinical bridge
Deanne Giannola, PA-C
Krista
Adriana
Chrissy
Enrique
MSK is the beachhead. The method extends.
Integrated mental health
Chronic pain carries 5× the rate of anxiety and depression. The same objective-measurement method extends to the mental-health dimension of MSK.
Health systems & payers
Rural health systems, FQHCs, and payers — sequenced after the employer wedge is proven.
Pharma & GLP-1
The objective standard for the MSK half of the GLP-1 care equation.
Stop managing MSK blind.
See how objective, physician-validated MSK measurement redirects waste and proves what works across your population.
The objective standard, while the window is open.
Physician-led, ecosystem-validated, five years of clinical signal. Request the investor materials for traction, market, and roadmap.
Set up a demo & meet Jessica.
Our agentic AI will lead you through your first MSK assessment — experience Smart Data firsthand. The future of MSK begins here.